ArticleGeneral thoracic and cardiovascular surgery cases2023
Myxoid solitary fibrous tumor with rapid growth due to increased mucinous components: a case report.
Article in General thoracic and cardiovascular surgery cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMyxoid solitary fibrous tumors are defined as solitary fibrous tumors with ≥ 50% mucinous components. As they are a rare type of pleural tumor, no reports on their rapid growth before surgery exist. CASE PRESENTATION: Herein, we report the case of a 63-year-old male patient with a myxoid solitary fibrous tumor. The tumor had grown rapidly from 27 to 50 mm over 6 months, and a contrast-enhancing area was observed in approximately one-quarter of the tumor on computed tomography. The tumor was located in the parietal pleura at the ventral part of the left fourth intercostal space without adhesion or invasion into surrounding organs. It was completely resected via video-assisted thoracic surgery. Based on histopathological and immunohistochemical findings, the tumor was identified as a myxoid solitary fibrous tumor. The patient was discharged on postoperative day 2 and has had recurrence-free survival for 6 months postoperatively.
conclusionsTo the best of our knowledge, this is the first case to report the rapid growth of myxoid solitary fibrous tumor despite its predominantly benign nature. Myxoid solitary fibrous tumors should be considered in the differential diagnosis of rapidly growing preoperative tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.